ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,469.94
      0.01%
      US Tech 100
      19,177.51
      0.01%
      Dow Jones
      39,160.09
      0.12%
      Brent Oil
      84.865
      0.81%
      Bitcoin
      61,205.75
      -0.97%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Canada
      5. TSXV

      6. Ceapro Inc (CZO) Quote

      Ceapro Inc

      Ceapro Inc (CZO)

      TSXV
      0.225
      0.00
      ( 0.00% )
      Updated: 20:00:00
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      0.225
      Bid
      0.16
      Ask
      0.30
      Volume
      -
      0.00 Day's Range 0.00
      0.15 52 Week Range 0.54
      Market Cap
      17.224M
      Previous Close
      0.225
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      38,130
      Shares Outstanding
      78,293,000
      Dividend Yield
      -
      PE Ratio
      -3.65
      Earnings Per Share (EPS)
      -0.06
      Revenue
      9.63M
      Net Profit
      -4.71M

      About Ceapro Inc

      Sector
      Medicinal Chems,botanicl Pds
      Industry
      Medicinal Chems,botanicl Pds
      Website
      www.ceapro.com
      Headquarters
      Edmonton, Alberta, Can
      Founded
      1970
      Ceapro Inc is listed in the Medicinal Chems,botanicl Pds sector of the TSX Venture Exchange with ticker CZO. The last closing price for Ceapro was $0.23. Over the last year, Ceapro shares have traded in a share price range of $ 0.15 to $ 0.54.

      Ceapro currently has 78,293,000 shares outstanding. The market capitalization of Ceapro is $17.22 million. Ceapro has a price to earnings ratio (PE ratio) of -3.65.

      CZO Latest News

      More News

      FeaturedPOET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program

      4 hours ago

      Aeterna Zentaris and Ceapro Complete Merger Transaction

      TORONTO and EDMONTON, Alberta, June 03, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”) and Ceapro Inc. (TSX-V: CZO) (OTCQX: CRPOF...

      June 03 2024
      GlobeNewswire Inc.

      Aeterna Zentaris and Ceapro Complete Merger Transaction

      TORONTO and EDMONTON, June 03, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”) and Ceapro Inc. (TSX-V: CZO) (OTCQX: CRPOF) (“Ceapro”), two...

      June 03 2024
      GlobeNewswire Inc.

      Suspension de la négociation par l'Organisme canadien de réglementation des investissements - CZO

      Suspension de la négociation par l'Organisme canadien de réglementation des investissements - CZO Canada NewsWire VANCOUVER, BC, le 3 juin 2024 VANCOUVER, BC, le 3 juin 2024 /CNW/...

      June 03 2024
      PR Newswire (Canada)

      Canadian Investment Regulatory Organization Trading Halt - CZO

      Canadian Investment Regulatory Organization Trading Halt - CZO Canada NewsWire VANCOUVER, BC, June 3, 2024 VANCOUVER, BC, June 3, 2024 /CNW/ - The following issues have been halted by...

      June 03 2024
      PR Newswire (Canada)

      Ceapro Inc. Reports Financial Results for First Quarter 2024 and Provides Corporate Update

      – Q1 2024 marked by significant advancement of R&D projects focused on avenanthramide Phase 1-2a clinical study and the processing of yeast beta glucan along with the building of pilot scale...

      May 29 2024
      GlobeNewswire Inc.

      Ceapro Inc. Reports 2023 Financial Results and Operational Highlights

      – 2023 marked by Ceapro’s achievement of key milestones and progress toward its next phase of growth – R&D activities focused on advancement of avenanthramide Phase 1-2a clinical study and the...

      April 29 2024
      GlobeNewswire Inc.

      Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris

      TORONTO and EDMONTON, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna") and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro”) are pleased to...

      March 28 2024
      GlobeNewswire Inc.

      Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

      TORONTO and EDMONTON, Alberta, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna”) and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro”) are pleased...

      March 12 2024
      GlobeNewswire Inc.

      Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

      TORONTO and EDMONTON, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna”) and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro”) are pleased to...

      March 12 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      4-0.045-16.66666666670.270.270.225603330.26141436CS
      12-0.01-4.255319148940.2350.2950.225381300.26339732CS
      260.02512.50.20.2950.15494240.23383647CS
      52-0.205-47.67441860470.430.540.15436050.29221912CS
      156-0.445-66.41791044780.670.820.15349250.48441624CS
      260-0.105-31.81818181820.330.980.14411050.49937931CS

      Market Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      WENAANEW MEDICAL INC
      $ 3.91
      (136.97%)
      		79.33M
      OPTXSyntec Optics Holdings Inc
      $ 4.5812
      (94.94%)
      		31.34M
      FFIEFaraday Future Intelligent Electric Inc
      $ 0.47
      (77.36%)
      		546.62M
      CMAXCareMax Inc
      $ 3.281
      (72.68%)
      		7.01M
      AIEVThunder Power Holdings Inc
      $ 2.3585
      (37.12%)
      		29.17M
      CNSPCNS Pharmaceuticals Inc
      $ 1.77
      (-37.68%)
      		1.34M
      GRIGRI Bio Inc
      $ 1.87
      (-37.04%)
      		629.25k
      NUWENewellis Inc
      $ 0.14195
      (-34.83%)
      		9.78M
      LYELLyell Immunopharma Inc
      $ 1.345
      (-34.07%)
      		8.9M
      BJDXBluejay Diagnostics Inc
      $ 1.86
      (-32.36%)
      		2.02M
      FFIEFaraday Future Intelligent Electric Inc
      $ 0.47
      (77.36%)
      		546.62M
      NVDANVIDIA Corporation
      $ 123.855
      (-1.77%)
      		241.22M
      RIVNRivian Automotive Inc
      $ 14.3859
      (20.28%)
      		205.51M
      WENAANEW MEDICAL INC
      $ 3.91
      (136.97%)
      		79.33M
      SQQQProShares UltraPro Short QQQ
      $ 8.2305
      (-1.90%)
      		75.41M

      CZO Discussion

      View Posts
      stocker11 stocker11 7 years ago
      Have they started testing the product for Cholesterol reduction.
      👍️0
      stocker11 stocker11 7 years ago
      Looking to buy in soon - should I wait until for the K is filed at the end of the month?
      👍️0
      Michon Michon 7 years ago
      What make's this stock special?
      👍️0
      notofthisworld notofthisworld 7 years ago
      This article underlines the potential of this company.

      http://www.theglobeandmail.com/globe-investor/investment-ideas/why-this-canadian-biotech-firms-cheap-stock-is-a-hidden-gem/article33325243/
      👍️0
      notofthisworld notofthisworld 7 years ago
      This won't be under 2$ for much longer.
      👍️0

      Your Recent History

      TSXV
      CZO
      Ceapro
      BIT
      UC7C1K
      Unicredit Bank
      TG
      A189UN
      ASML Holdings NV
      BIT
      UB5173
      Unicredit Bank
      USOTC
      PHCRF
      Healius (PK)
      LSE
      85XS
      Hsbc Bk. 23
      USOTC
      GSREF
      Greenstone Resources (CE)
      LSE
      SN39
      Barclays 27
      USOTC
      CNDHF
      Conduit (PK)
      Delayed Upgrade Clock